Tag(s):
ECJ told to dismiss AstraZeneca appeal
Tuesday, 15 May 2012
The European Court of Justice’s (ECJ) advocate general Jan Mazak has urged the court to dismiss the appeal brought by AstraZeneca against a €60 million fine imposed by the European Commission and upheld by the EU General Court.
EC drops AstraZeneca/Nycomed probe
Friday, 02 March 2012
The European Commission has dropped its investigation of AstraZeneca and Nycomed, having found no evidence that the pharmaceutical companies conspired to delay generic drugs from entering the market.
AstraZeneca pays to settle Tropol XL antitrust case
Tuesday, 27 September 2011
Drug maker AstraZeneca has agreed to pay US$20 million to settle a potential class action lawsuit accusing the company of using sham patent litigation to unfairly monopolise the market for the branded heart disease medication Tropol XL.
DG Comp targets pharmaceuticals again
Premium Article - Monday, 06 December 2010
The European Commission has raided pharmaceutical companies over alleged abuse of dominance in delaying generic drugs from entering the market.
California ends pass-on antitrust defence
Premium Article - Wednesday, 14 July 2010
The California Supreme Court has ruled that the state’s legislature did not intend for the Cartwright Act – California’s antitrust law – to allow alleged cartelists to use a pass-on defence to thwart private lawsuits.
AstraZeneca fine reduced
Premium Article - Thursday, 01 July 2010
Europe’s General Court today rejected AstraZeneca's appeal against a fine for anti-competitive practice, reducing the penalty instead.
AstraZeneca settles "do the math" drug case
Premium Article - Monday, 21 June 2010
Drug maker AstraZeneca has agreed to pay US$103 million to settle an antitrust suit in which customers and third-party purchasers claimed the company offered steep discounts to consumers in an attempt to boost its market share.
New Zealand Supreme Court takes shot at subpoena power
Premium Article - Friday, 28 August 2009
The Supreme Court of New Zealand has told the Commerce Commission it overstepped its power when issuing a subpoena to AstraZeneca during an investigation of the pharmaceutical sector.
Search GCR
Register for Free GCR Daily News
GCR April/May 2012
In this issue:
Survey: Australia • Howrey: in their words • Rod Sims interview • GCR cartel roundtable • GCR Live Law Leaders Asia-Pacific
GCR Live Events
Jun
20
GCR Live Financial Services and Competition Law 2012
Organiser: Global Competition Review
Wed, 20th June
London, United Kingdom
Jun
28
GCR Live Consumer Goods and Retail - Latin America 2012
Organiser: Global Competition Review
Thu, 28th June
São Paulo, Brasil
Oct
09
Nov
13
GCR Live 4th Annual Competition Law Review
Organiser: Global Competition Review
Tue, 13th November - Wed, 14th November
Brussels, Belgium
Feb
08
